Ledger.Open graph →
SEC Form D · filed April 4, 2014

Transplant Genomics Inc

Offering
$3.0M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BROOKLINE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Stanley Rose · Madison, WIExec · DirectorMichael Abecassis · Highland Park, ILDirectorDaniel Salomon · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗